- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Toshiba develops gamma camera upgrades
Toshiba's nuclear medicine division is adding enhancements to its line of gamma cameras.The Tustin, CA, vendor is planning to extend its transmission-emissionartifact-correction technique from its triple-head gamma camerasto its dual-head systems,
Toshiba's nuclear medicine division is adding enhancements to its line of gamma cameras.The Tustin, CA, vendor is planning to extend its transmission-emissionartifact-correction technique from its triple-head gamma camerasto its dual-head systems, according to Steve Sickels, divisionmanager.
Toshiba displayed transmission-emission attenuation correctionas a work-in-progress at last year's Radiological Society of NorthAmerica meeting. The technique was shown on Toshiba's triple-headGCA-9300A camera, but Toshiba also has an active R&D programin Japan to bring the technology to the dual-head GCA-7200A, accordingto Sickels. The dual-head version, which is also a work-in-progress,will involve a combination of a stationary line source of radioactivityand collimation, he said. GCA-7200A is an opposable dual-headcamera.
Toshiba also has a program in the works to develop 511-keVcollimators for SPECT imaging with fluorodeoxyglucose (FDG), Sickelssaid.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
